DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/zndwr6/left_ventricular_h) has announced the addition of Global Markets Direct's new report "Left Ventricular Hypertrophy - Pipeline Review, H1 2012" to their offering.
Global Markets Direct's, 'Left Ventricular Hypertrophy - Pipeline Review, H1 2012', provides an overview of the Left Ventricular Hypertrophy therapeutic pipeline. This report provides information on the therapeutic development for Left Ventricular Hypertrophy, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Left Ventricular Hypertrophy. 'Left Ventricular Hypertrophy - Pipeline Review, H1 2012' is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.
Scope
- A snapshot of the global therapeutic scenario for Left Ventricular Hypertrophy.
- A review of the Left Ventricular Hypertrophy products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
- Coverage of the Left Ventricular Hypertrophy pipeline on the basis of route of administration and molecule type.
- Profiles of late-stage pipeline products featuring sections on product description, mechanism of action and research & development progress.
Reasons to buy
- Identify and understand important and diverse types of therapeutics under development for Left Ventricular Hypertrophy.
- Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
- Plan mergers and acquisitions effectively by identifying players with the most promising pipeline.
- Devise corrective measures for pipeline projects by understanding Left Ventricular Hypertrophy pipeline depth and focus of Left Ventricular Hypertrophy therapeutics.
Keywords
Left Ventricular Hypertrophy Therapeutic Products under Development, Key Players in Left Ventricular Hypertrophy Therapeutics, Left Ventricular Hypertrophy Pipeline Overview, Left Ventricular Hypertrophy Pipeline, Left Ventricular Hypertrophy Pipeline Assessment
For more information visit http://www.researchandmarkets.com/research/zndwr6/left_ventricular_h
Source: Global Markets Direct